United Therapeutics | UTHR - Interest Expense On Debt



United Therapeutics reported $7.3M in Interest Expense on Debt for its fiscal quarter ending in June of 2025.


Interest Expense On Debt Change Date
Amarin USD 3K 3K Dec/2024
Ardelyx USD 6.58M 2.61M Jun/2025
Baxter International USD 81M 19M Mar/2025
Bayer 495M 89M Jun/2025
Biogen USD 72.6M 12.6M Jun/2025
BioMarin Pharmaceutical USD 2.68M 184K Jun/2025
Gilead Sciences USD 254M 6M Jun/2025
GlaxoSmithKline 184M 22M Jun/2025
Halozyme Therapeutics USD 4.39M 131K Jun/2025
Insmed USD 21.24M 1.5M Jun/2025
Ionis Pharmaceuticals USD 19M 0 Jun/2025
J&J USD 128M 9M Mar/2025
Moderna USD 1000K 0 Jun/2025
Pfizer USD 654M 0 Jun/2025
PTC Therapeutics USD 30.36M 4.03M Jun/2025
Regeneron Pharmaceuticals USD 3.6M 5.1M Jun/2025
Sarepta Therapeutics USD 5.23M 725K Jun/2025
Teva Pharmaceutical Industries USD 252M 40M Jun/2025
United Therapeutics USD 7.3M 1.2M Jun/2025
Vertex Pharmaceuticals USD 3.7M 900K Jun/2025